Produkty 2590-41-2

CAS 2590-41-2 występuje w naszej ofercie pod nazwami: Dehydronandrolon, 6-Dehydro Nandrolone Acetate, 6–Dehydronandrolone Acetate, 6-Dehydronandrolone Acetate, >98.0%(HPLC), 6-Dehydronandrolone acetate, 99.94%. Oferty producentów: Hubei YoungXin, TRC, GLPBio, Biosynth, TCI. Dostępne opakowania: 10mg, 25mg, 50mg, 100mg, 200mg, 1g, 500mg, 100g.

Dehydronandrolon
Hubei YoungXin, Biosynth
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 10
Zobacz produkt
6-Dehydro Nandrolone Acetate
TRC
  • opakowanie: 100mg, 1g, 500mg
  • Warianty: 3
Zobacz produkt
6–Dehydronandrolone Acetate
GLPBio
  • opakowanie: 100g, 1g, 25g, 5g
  • Warianty: 4
od 512,79
Zobacz produkt
6-Dehydronandrolone Acetate, >98.0%(HPLC)
TCI
  • opakowanie: 1g, 5g
  • Warianty: 2
od 221,61
Zobacz produkt
6-Dehydronandrolone acetate, 99.94%
MedChemExpress
  • opakowanie: 1 g, 5 g
  • Warianty: 2
od 240,74
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,8,9,10,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate (CAS 2590-41-2) to związek chemiczny o wzorze sumarycznym C20H26O3 i masie molowej 314.4 g/mol. Nazwa systematyczna IUPAC: [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,8,9,10,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate. InChIKey: OGUASZAAVFYYIL-XGXHKTLJSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H26O3
Masa molowa314.4 g/mol
Nazwa IUPAC[(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,8,9,10,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
InChIKeyOGUASZAAVFYYIL-XGXHKTLJSA-N
SMILESCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@H]34)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (17beta)-3-Oxoestra-4,6-dien-17-yl acetate, 6-Dehydronandrolone acetate, dehydronandrolon, Estra-4,6-dien-3-one, 17-(acetyloxy)-, (17b)-, Dehydronandrolone Acetate, OGUASZAAVFYYIL-XGXHKTLJSA-N, 6-Dehydro-19-nortestosterone Acetate, 17beta-acetoxy-estra-4,6-dien-3-one, 3-Oxoestra-4,6-dien-17beta-yl acetate, (17beta)-17-(acetyloxy)estra-4,6-dien-3-one
Izomery (ten sam wzór sumaryczny)
(8S,13S,14S)-13-methylspiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-one C20H26O3
(8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione C20H26O3
2-tert-butyl-1-[2-(4-methoxyphenoxy)ethoxy]-4-methylbenzene C20H26O3
trans-(2R,3S)-2-ethyl-3-hydroxy-2-[(2E)-2-(6-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)ethyl]cyclopentan-1-one C20H26O3
(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C20H26O3
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(8S,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate C20H26O3
(8S,13S,14S,17S)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(1S,4S,12S,13R,16R,17R)-17-(hydroxymethyl)-12-methyl-8-oxapentacyclo[14.2.1.01,13.04,12.05,9]nonadeca-5(9),6,10-trien-17-ol C20H26O3
(5S,8R,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-2,4,5,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-dione C20H26O3